FdaApplication
ANDA 202229
Identifiers
- fda_app_no: ANDA202229
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2013-07-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACAMPROSATE CALCIUM | ACAMPROSATE CALCIUM | 333MG | TABLET, DELAYED RELEASE;ORAL |
1 product